Urine kidney safety biomarkers improve understanding of indirect intra-renal injury potential in dogs with a drug-induced prerenal azotemia

• Published in: Toxicology (Amsterdam) 2020-06, Vol.439, p.152462, Article 152462
• Main Authors: Gu, Yi-Zhong, Vlasakova, Katerina, Darbes, Jarig, Wang, Erjia, Ferraro, Jude, Glaab, Warren E., Sistare, Frank D.
• Format: Article
• Language: English
• Subjects: Canine model; Kidney safety biomarkers; Prerenal azotemia
• ISSN: 0300-483X; 1879-3185
• DOI: 10.1016/j.tox.2020.152462

•A canine model of prerenal azotemia has been established.•BUN and sCr often become false positives of kidney injury under prerenal azotemia.•Urine kidney biomarkers are better indicators for intra-renal injury in azotemia. Drug-induced kidney injury (DIKI) is a frequent occurrence in nonclinical drug development. It is well established that novel urine kidney safety biomarkers will outperform urea nitrogen (BUN) and serum creatinine (sCr) for monitoring direct drug injury to the kidney across numerous compounds spanning diverse mechanisms and efforts are underway for a formal regulatory clinical qualification. However, it remains unclear how these novel biomarkers will perform under prerenal azotemia when BUN and sCr are elevated but no intra-renal injury is suspected. This lack of knowledge is largely due to the dearth of such nonclinical animal models. We report here that treatment of dogs with a potent antihypertensive compound MK-5478 at a suprapharmacologic dose for up to 9 days results in the development of prerenal azotemia and, in some dogs, kidney toxicity through the dual sustained effects of MK-5478 as a nitric oxide donor and an angiotensin II receptor blocker (ARB). While conventional serum biomarkers BUN, and often sCr as well, were highly elevated in these dogs with or without kidney damage, urine kidney biomarkers clusterin (CLU) and neutrophil gelatinase-associated lipocalin (NGAL) showed increases only in dogs with kidney histopathologic changes following the sustained period of prerenal azotemia. Urine albumin (ALB) and total protein also tracked with kidney lesions but with less sensitivity. Thus, we present evidence for the first time that urine kidney safety biomarkers used together with BUN and sCr can distinguish intra-renal injury among dogs with prerenal azotemia while the conventional serum biomarkers alone are ambiguous, either being interpreted as false positives of kidney injury, or dismissed under circumstances as benign without appreciation for a threshold of impending injury.